Bone Biologics(BBLG)

超过5%股东持股披露「修订」

Bone Biologics(BBLG)02-15 00:05

$Bone Biologics(BBLG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001052  Act: 34  Size: 54 KB 网页链接

当期报告

Bone Biologics(BBLG)03-07 05:25

$Bone Biologics(BBLG)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-009033  Act: 34  Size: 1 MB 网页链接

超过5%股东持股披露

Bone Biologics(BBLG)03-15 05:15

$Bone Biologics(BBLG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-022661  Act: 34  Size: 66 KB 网页链接

当期报告

Bone Biologics(BBLG)03-01 21:15

$Bone Biologics(BBLG)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-008412  Act: 34  Size: 281 KB 网页链接

超过5%股东持股披露「修订」

Bone Biologics(BBLG)02-15 07:45

$Bone Biologics(BBLG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001753926-24-000305  Act: 34  Size: 72 KB 网页链接

年度财报

Bone Biologics(BBLG)02-22 06:15

$Bone Biologics(BBLG)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-007432  Act: 34  Size: 6 MB 网页链接

超过5%股东持股披露「修订」

Bone Biologics(BBLG)02-14 09:05

$Bone Biologics(BBLG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000559  Act: 34  Size: 76 KB 网页链接

招股说明书

Bone Biologics(BBLG)03-05 06:25

$Bone Biologics(BBLG)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001493152-24-008713  Act: 33  Size: 367 KB 网页链接

当期报告

Bone Biologics(BBLG)03-16 04:55

$Bone Biologics(BBLG)$ 8-K Current report, item 5.02 Accession Number: 0001493152-24-010114  Act: 34  Size: 265 KB 网页链接

招股说明书

Bone Biologics(BBLG)01-31 06:15

$Bone Biologics(BBLG)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-24-004349  Act: 33  Size: 9 MB 网页链接

讨论

韩信超短2023-12-28 23:16

$Bone Biologics(BBLG)$ 风向标到这里来了查看全文

讨论

不入流资讯2023-06-15 22:06

$Bone Biologics(BBLG)$ Biologics stock plummets more than 50% after stock offering prices at deep discount查看全文

Bone Biologics在美东时间2月9日15:39:02停牌 15:44:02恢复交易

Bone Biologics(BBLG)在美国东部时间2月9日15:39:02停牌。 停牌原因编码：LUDP 停牌原因：涨跌幅波动异常交易暂停 恢复日期：2月9日 恢复报价时间：15:39:02 恢复交易时间：15:44:02 网页链接

Bone Biologics盘前跌47% 以每股1.94美元公开发行254万股股票

来源：格隆汇 格隆汇6月15日丨Bone Biologics (BBLG.US)盘前跌47.07%，报2.08美元。Bone Biologics以每股1.97美元的价格公开发行254万股股票，总募集资金总额约为500万美元。 责任编辑：郭明煜 网页链接

当期报告

$Bone Biologics(BBLG)$ 8-K Current report, item 5.02 Accession Number: 0001493152-24-010114  Act: 34  Size: 265 KB 网页链接

超过5%股东持股披露

$Bone Biologics(BBLG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-022661  Act: 34  Size: 66 KB 网页链接

当期报告

$Bone Biologics(BBLG)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-009033  Act: 34  Size: 1 MB 网页链接

生效批准

$Bone Biologics(BBLG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000598  Act: 33  Size: 2 KB 网页链接

招股说明书

$Bone Biologics(BBLG)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001493152-24-008713  Act: 33  Size: 367 KB 网页链接

当期报告

$Bone Biologics(BBLG)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-008412  Act: 34  Size: 281 KB 网页链接

招股说明书「补充」

$Bone Biologics(BBLG)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-24-007837  Act: 33  Size: 418 KB 网页链接

招股说明书「补充」

$Bone Biologics(BBLG)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-24-007706  Act: 33  Size: 1 MB 网页链接

年度财报

$Bone Biologics(BBLG)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-007432  Act: 34  Size: 6 MB 网页链接

超过5%股东持股披露「修订」

$Bone Biologics(BBLG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001753926-24-000305  Act: 34  Size: 72 KB 网页链接